Model
Edge
Oyster Point Pharma Inc.
0001720725
Filing type
SC14D9C
Filing date
Nov 15, 2022
Updated
Nov 16, 2022 ยท 9:24 AM
Copy reference
Filing
SC14D9C
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Exhibits
EX-99.1
EX-99.1
EX-99.2
EX-99.2